Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -41.89x is in line with its 4-year average of -39.60x, near the high end of its 4-year range (-829.25x–-16.32x).
9.66% above its 12-month average of -46.37x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -60.87x.
INTEREST COVERAGE RATIO
-41.89x
INTEREST COVERAGE RATIO AVG TTM
-46.37x
INTEREST COVERAGE RATIO AVG 3Y
-32.63x
INTEREST COVERAGE RATIO AVG 5Y
-39.60x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.66%
CURRENT VS 3Y AVG
-28.38%
CURRENT VS 5Y AVG
-5.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-550.47%
vs the sector median at left
Vera Therapeutics, Inc.
Market Cap
$2.11B
Interest Coverage Ratio
-41.89x
TTM Avg
-46.37x
3Y Avg
-32.63x
5Y Avg
-39.60x
Market Cap
$2.11B
Interest Coverage Ratio
14.46x
TTM Avg
13.87x
3Y Avg
10.91x
5Y Avg
11.49x
Market Cap
$2.11B
Interest Coverage Ratio
N/A
TTM Avg
3504.00x
3Y Avg
3504.00x
5Y Avg
3504.00x
Market Cap
$2.13B
Interest Coverage Ratio
-4.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.06B
Interest Coverage Ratio
-73.44x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.06B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.17B
Interest Coverage Ratio
-0.25x
TTM Avg
23.23x
3Y Avg
12.79x
5Y Avg
10.35x
Market Cap
$2.05B
Interest Coverage Ratio
7.10x
TTM Avg
7.23x
3Y Avg
7.23x
5Y Avg
136.60x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | $2.11B | -41.89x | -46.37x | -32.63x | -39.60x |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 14.46x | 13.87x | 10.91x | 11.49x |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | N/A | 3504.00x | 3504.00x | 3504.00x |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | -4.65x | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.08B | 0.52x | 0.48x | 0.48x | 0.48x |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -73.44x | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | N/A | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | -0.25x | 23.23x | 12.79x | 10.35x |
| Vericel Corporation (VCEL)vs › | $2.05B | 7.10x | 7.23x | 7.23x | 136.60x |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
Interest Coverage
-41.9x
Debt/Equity
0.18
Current Ratio
10.92
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -60.87x |
| 2026-03-31 | -68.64x |
| 2025-12-31 | -16.74x |
| 2025-09-30 | -42.82x |
| 2025-06-30 | -42.76x |
| 2025-03-31 | -31.92x |
| 2024-12-31 | -26.14x |
| 2024-09-30 | -25.72x |
| 2024-06-30 | -19.53x |
| 2024-03-31 | -16.32x |
| 2023-12-31 | -25.59x |
| 2023-09-30 | -23.07x |
| 2023-06-30 | -24.04x |
| 2023-03-31 | -35.76x |
| 2022-12-31 | -56.06x |
| 2022-09-30 | -171.73x |
| 2022-06-30 | -117.63x |
| 2022-03-31 | -144.25x |
| 2021-12-31 | -829.25x |
| 2020-12-31 | -2837.33x |
| 2020-09-30 | -63.08x |
| 2020-06-30 | -50.37x |
| 2020-03-31 | -102.96x |
